Brecanavir
From Self-sufficiency
| File:Brecanavir.png | |
| Systematic (IUPAC) name | |
|---|---|
|
[(3R,3aS,6aR)-2,3,3a,4,5,6a-Hexahydrofuro[5,4-b]furan-3-yl] N-[(2S,3R)-4-(1,3-benzodioxol-5-ylsulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate | |
| Identifiers | |
| CAS Number | 313682-08-5 |
| ATC code | none |
| PubChem | CID 5743186 |
| Chemical data | |
| Formula | C33H41N3O10S2 |
| Molar mass | 703.82[[Script error: No such module "String".]] |
Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.[1]
On December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.[2]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 50px | This antiinfective drug article is a stub. You can help ssf by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ "GlaxoSmithKline discontinues clinical development of investigational protease inhibitor brecanavir (640385)" (Press release). GlaxoSmithKline. 2006-12-18. http://www.gsk.com/media/pressreleases/2006/2006_12_18_GSK945.htm. Retrieved 2008-06-11.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Protease inhibitors
- Thiazoles
- Benzodioxoles
- Phenol ethers
- Carbamates
- Furofurans
- Antiinfective agent stubs
- 2Fix
